Great Point Partners
Private Equity SEC-registered adviser
Legal name: Great Point Partners, LLC
AUM
$1.8B
Regulatory AUM
Private funds
17
Private Equity 15 · Hedge Fund 2
Private fund assets
$1.8B
Gross asset value
Employees
28
Last Form D raise
Dec 2025
Most recent fund filing
From SEC Form ADV filing (filed Mar 31, 2026). View on SEC
People(2)
Owners and executive officers named on the firm's SEC Form ADV.
J
K
Funds(17)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Biomedical Offshore Value Fund, LTD. | Hedge Fund | $178.8M | $772.3M | 73 | Dec 2025 | Warm |
| Gpp - Cf I, LP | Private Equity | $25.6M | $36.4M | 62 | Dec 2022 | Cold |
| Great Point Partners IV, L.P. | Private Equity | $658.5M | $432.0M | 125 | Apr 2022 | Cold |
| Biomedical Value Fund, L.P. | Hedge Fund | $381.4M | $50.7M | 98 | Dec 2021 | Cold |
| Great Point Partners Iii-A, L.P. | Private Equity | $52.7M | $46.1M | 23 | Aug 2019 | Cold |
| Great Point Partners III, LP | Private Equity | $299.0M | $116.2M | 71 | Sep 2018 | Cold |
| Gpp IV - Lyocontract, LLC | Private Equity | $77.7M | — | — | — | |
| Gpp III - Pcm, LLC | Private Equity | $40.2M | — | — | — | |
| Gpp III - Ephicacy, LLC | Private Equity | $21.9M | — | — | — | |
| Great Point Partners II, LP | Private Equity | $21.7M | — | — | — | |
| Great Point Partners Ii-A, LP | Private Equity | $6.6M | — | — | — | |
| Gpp III - Mlm, LLC | Private Equity | $5.4M | — | — | — | |
| Gpp IV - Ludi, LLC | Private Equity | $4.6M | — | — | — | |
| Gpp III - Ixcells, LLC | Private Equity | $1.8M | — | — | — | |
| Gpp IV - Eutecma, LLC | Private Equity | $988K | — | — | — |
Board seats
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
No board seats matched from SEC filings yet.
Regulatory identifiers
- CRD number
- 158423
- SEC file number
- 801-73834
- CIK
- 1281446
Sources
- SEC Form ADV Oct 14, 2026